866-997-4948(US-Canada Toll Free)

China Schizophrenia Drugs Market Research Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 96 Pages

The global Schizophrenia Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Schizophrenia Drugs development status and future trend in China, focuses on top players in China, also splits Schizophrenia Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
Johnson & Johnson
Bristol-Myers Squibb
Otsuka Pharma
AstraZeneca
Sumitomo Dainippon
Eli Lilly
Alkermes
Vanda Pharma
Allergan
Pfizer

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Oral Antipsychotics
Injectable Antipsychotics

On the basis of the end users/application, this report covers
Hospital
Clinic

Table of Contents

China Schizophrenia Drugs Market Research Report 2018
1 Schizophrenia Drugs Overview
1.1 Product Overview and Scope of Schizophrenia Drugs
1.2 Classification of Schizophrenia Drugs by Product Category
1.2.1 China Schizophrenia Drugs Sales (K Units) Comparison by Type (2013-2025)
1.2.2 China Schizophrenia Drugs Sales (K Units) Market Share by Type in 2017
1.2.3 Oral Antipsychotics
1.2.4 Injectable Antipsychotics
1.3 China Schizophrenia Drugs Market by Application/End Users
1.3.1 China Schizophrenia Drugs Sales (K Units) and Market Share Comparison by Applications (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 China Schizophrenia Drugs Market by Region
1.4.1 China Schizophrenia Drugs Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Schizophrenia Drugs Status and Prospect (2013-2025)
1.4.3 East China Schizophrenia Drugs Status and Prospect (2013-2025)
1.4.4 Southwest China Schizophrenia Drugs Status and Prospect (2013-2025)
1.4.5 Northeast China Schizophrenia Drugs Status and Prospect (2013-2025)
1.4.6 North China Schizophrenia Drugs Status and Prospect (2013-2025)
1.4.7 Central China Schizophrenia Drugs Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Schizophrenia Drugs (2013-2025)
1.5.1 China Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
1.5.2 China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 China Schizophrenia Drugs Market Competition by Players/Manufacturers
2.1 China Schizophrenia Drugs Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Schizophrenia Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Schizophrenia Drugs Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Schizophrenia Drugs Market Competitive Situation and Trends
2.4.1 China Schizophrenia Drugs Market Concentration Rate
2.4.2 China Schizophrenia Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Schizophrenia Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 China Schizophrenia Drugs Sales and Revenue by Region (2013-2018)
3.1 China Schizophrenia Drugs Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Schizophrenia Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Schizophrenia Drugs Price (USD/Unit) by Regions (2013-2018)

4 China Schizophrenia Drugs Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Schizophrenia Drugs Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Schizophrenia Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Schizophrenia Drugs Price (USD/Unit) by Type (2013-2018)
4.4 China Schizophrenia Drugs Sales Growth Rate (%) by Type (2013-2018)

5 China Schizophrenia Drugs Sales by Application (2013-2018)
5.1 China Schizophrenia Drugs Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Schizophrenia Drugs Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 China Schizophrenia Drugs Players/Suppliers Profiles and Sales Data
6.1 Johnson & Johnson
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Schizophrenia Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Johnson & Johnson Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Schizophrenia Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bristol-Myers Squibb Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Otsuka Pharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Schizophrenia Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Otsuka Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 AstraZeneca
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Schizophrenia Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AstraZeneca Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 Sumitomo Dainippon
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Schizophrenia Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sumitomo Dainippon Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 Eli Lilly
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Schizophrenia Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eli Lilly Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
6.7 Alkermes
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Schizophrenia Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Alkermes Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.7.4 Main Business/Business Overview
6.8 Vanda Pharma
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Schizophrenia Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Vanda Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.8.4 Main Business/Business Overview
6.9 Allergan
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Schizophrenia Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Allergan Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.9.4 Main Business/Business Overview
6.10 Pfizer
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Schizophrenia Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Pfizer Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.10.4 Main Business/Business Overview

7 Schizophrenia Drugs Manufacturing Cost Analysis
7.1 Schizophrenia Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Schizophrenia Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Schizophrenia Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Schizophrenia Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 China Schizophrenia Drugs Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Schizophrenia Drugs Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Schizophrenia Drugs Sales (K Units) Forecast by Type (2018-2025)
11.3 China Schizophrenia Drugs Sales (K Units) Forecast by Application (2018-2025)
11.4 China Schizophrenia Drugs Sales (K Units) Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Table

List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Schizophrenia Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Schizophrenia Drugs Sales (K Units) by Application (2013-2025)
Figure Product Picture of Schizophrenia Drugs
Table China Schizophrenia Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Schizophrenia Drugs Sales Volume Market Share by Types in 2017
Figure Oral Antipsychotics Product Picture
Figure Injectable Antipsychotics Product Picture
Figure China Schizophrenia Drugs Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Schizophrenia Drugs by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure South China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Schizophrenia Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Schizophrenia Drugs Sales of Key Players/Manufacturers (2013-2018)
Table China Schizophrenia Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Schizophrenia Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 China Schizophrenia Drugs Sales Share (%) by Players/Manufacturers
Table China Schizophrenia Drugs Revenue by Players/Manufacturers (2013-2018)
Table China Schizophrenia Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Schizophrenia Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Schizophrenia Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Schizophrenia Drugs Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Schizophrenia Drugs Average Price of Key Players/Manufacturers in 2017
Figure China Schizophrenia Drugs Market Share of Top 3 Players/Manufacturers
Figure China Schizophrenia Drugs Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Schizophrenia Drugs Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Schizophrenia Drugs Product Category
Table China Schizophrenia Drugs Sales (K Units) by Regions (2013-2018)
Table China Schizophrenia Drugs Sales Share (%) by Regions (2013-2018)
Figure China Schizophrenia Drugs Sales Share (%) by Regions (2013-2018)
Figure China Schizophrenia Drugs Sales Market Share (%) by Regions in 2017
Table China Schizophrenia Drugs Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Schizophrenia Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Schizophrenia Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Schizophrenia Drugs Revenue Market Share (%) by Regions in 2017
Table China Schizophrenia Drugs Price (USD/Unit) by Regions (2013-2018)
Table China Schizophrenia Drugs Sales (K Units) by Type (2013-2018)
Table China Schizophrenia Drugs Sales Share (%) by Type (2013-2018)
Figure China Schizophrenia Drugs Sales Share (%) by Type (2013-2018)
Figure China Schizophrenia Drugs Sales Market Share (%) by Type in 2017
Table China Schizophrenia Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Schizophrenia Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Schizophrenia Drugs by Type (2013-2018)
Figure Revenue Market Share of Schizophrenia Drugs by Type in 2017
Table China Schizophrenia Drugs Price (USD/Unit) by Types (2013-2018)
Figure China Schizophrenia Drugs Sales Growth Rate (%) by Type (2013-2018)
Table China Schizophrenia Drugs Sales (K Units) by Applications (2013-2018)
Table China Schizophrenia Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Schizophrenia Drugs Sales Market Share (%) by Application (2013-2018)
Figure China Schizophrenia Drugs Sales Market Share (%) by Application in 2017
Table China Schizophrenia Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure China Schizophrenia Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Johnson & Johnson Schizophrenia Drugs Basic Information List
Table Johnson & Johnson Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Johnson & Johnson Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Johnson & Johnson Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Johnson & Johnson Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Bristol-Myers Squibb Schizophrenia Drugs Basic Information List
Table Bristol-Myers Squibb Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bristol-Myers Squibb Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bristol-Myers Squibb Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Bristol-Myers Squibb Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Otsuka Pharma Schizophrenia Drugs Basic Information List
Table Otsuka Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Otsuka Pharma Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Otsuka Pharma Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Otsuka Pharma Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table AstraZeneca Schizophrenia Drugs Basic Information List
Table AstraZeneca Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AstraZeneca Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AstraZeneca Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure AstraZeneca Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Sumitomo Dainippon Schizophrenia Drugs Basic Information List
Table Sumitomo Dainippon Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sumitomo Dainippon Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sumitomo Dainippon Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Sumitomo Dainippon Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Eli Lilly Schizophrenia Drugs Basic Information List
Table Eli Lilly Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Eli Lilly Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Eli Lilly Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Eli Lilly Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Alkermes Schizophrenia Drugs Basic Information List
Table Alkermes Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Alkermes Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Alkermes Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Alkermes Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Vanda Pharma Schizophrenia Drugs Basic Information List
Table Vanda Pharma Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Vanda Pharma Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Vanda Pharma Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Vanda Pharma Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Allergan Schizophrenia Drugs Basic Information List
Table Allergan Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Allergan Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Allergan Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Allergan Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Pfizer Schizophrenia Drugs Basic Information List
Table Pfizer Schizophrenia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Pfizer Schizophrenia Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Pfizer Schizophrenia Drugs Sales Market Share (%) in China (2013-2018)
Figure Pfizer Schizophrenia Drugs Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Schizophrenia Drugs
Figure Manufacturing Process Analysis of Schizophrenia Drugs
Figure Schizophrenia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Schizophrenia Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Schizophrenia Drugs
Table Distributors/Traders List
Figure China Schizophrenia Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Schizophrenia Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Schizophrenia Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table China Schizophrenia Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Schizophrenia Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Schizophrenia Drugs Sales Volume Market Share Forecast by Type in 2025
Table China Schizophrenia Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure China Schizophrenia Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Schizophrenia Drugs Sales Volume Market Share Forecast by Application in 2025
Table China Schizophrenia Drugs Sales (K Units) Forecast by Regions (2018-2025)
Table China Schizophrenia Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Schizophrenia Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Schizophrenia Drugs Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *